These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 8997550)

  • 1. Neurochemical differences in the CSF between Binswanger's and Alzheimer's disease.
    Strittmatter M; Hamann GF; Grauer MT; Cramer H; Schimrigk K
    Dement Geriatr Cogn Disord; 1997; 8(1):34-42. PubMed ID: 8997550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Somatostatin, its molecular forms and monoaminergic transmitter metabolites in Binswanger's disease. Neurochemical-neuropathological considerations.
    Strittmatter M; Grauer MT; Hamann GF; Cramer H; Schimrigk K
    Neurodegeneration; 1996 Dec; 5(4):359-66. PubMed ID: 9117548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular forms of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Strittmatter M; Cramer H; Reuner C; Strubel D; Hamann G; Schimrigk K
    Biol Psychiatry; 1997 Jun; 41(11):1124-30. PubMed ID: 9146823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin-like immunoreactivity, its molecular forms and monoaminergic metabolites in aged and demented patients with Parkinson's disease--effect of L-Dopa.
    Strittmatter M; Hamann GF; Strubel D; Cramer H; Schimrigk K
    J Neural Transm (Vienna); 1996; 103(5):591-602. PubMed ID: 8811504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF beta-endorphin, HVA and 5-HIAA of dementia of the Alzheimer type and Binswanger's disease in the elderly.
    Lee S; Chiba T; Kitahama T; Kaieda R; Hagiwara M; Nagazumi A; Terashi A
    J Neural Transm Suppl; 1990; 30():45-55. PubMed ID: 1697333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CSF monoamine metabolites in old age dementias.
    Parnetti L; Gaiti A; Reboldi GP; Santucci C; Mecocci P; Brunetti M; Cadini D; Senin U
    Mol Chem Neuropathol; 1992; 16(1-2):143-57. PubMed ID: 1381590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parkinson's disease and dementia: clinical and neurochemical correlations.
    Strittmatter MM; Cramer H
    Neuroreport; 1992 May; 3(5):413-6. PubMed ID: 1378766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus.
    Cramer H; Schaudt D; Rissler K; Strubel D; Warter JM; Kuntzmann F
    J Neurol; 1985; 232(6):346-51. PubMed ID: 2416886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-aminobutyric acid and homovanillic acid concentration in the CSF of patients with senile dementia of Alzheimer's type.
    Zimmer R; Teelken AW; Trieling WB; Weber W; Weihmayr T; Lauter H
    Arch Neurol; 1984 Jun; 41(6):602-4. PubMed ID: 6721733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurotransmitters in dementia.
    Nakamura S; Koshimura K; Kato T; Yamao S; Iijima S; Nagata H; Miyata S; Fujiyoshi K; Okamoto K; Suga H
    Clin Ther; 1984; 7 Spec No():18-34. PubMed ID: 6152197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concentrations of monoamines and their metabolites in the cerebrospinal fluid from patients with senile dementia of the Alzheimer type and vascular dementia of the Binswanger type.
    Tohgi H; Ueno M; Abe T; Takahashi S; Nozaki Y
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):69-77. PubMed ID: 1540305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical markers in the cerebrospinal fluid of patients with Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis and normal controls.
    Hartikainen P; Reinikainen KJ; Soininen H; Sirviö J; Soikkeli R; Riekkinen PJ
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):53-68. PubMed ID: 1347220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-like immunoreactivity and acetylcholinesterase activities in cerebrospinal fluid of patients with Alzheimer disease and senile dementia of the Alzheimer type.
    Gomez S; Davous P; Rondot P; Faivre-Bauman A; Valade D; Puymirat J
    Psychoneuroendocrinology; 1986; 11(1):69-73. PubMed ID: 3517922
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A clinicopathological study of senile dementia of Alzheimer's type (SDAT) and white matter lesions of Binswanger's type].
    Meguro K; Matsushita M; Yoshida R; Otomo E; Yamaguchi S; Nakagawa T; Sasaki H
    Nihon Ronen Igakkai Zasshi; 1994 Mar; 31(3):226-31. PubMed ID: 8207874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF somatostatin-like immunoreactivity in dementia.
    Beal MF; Growdon JH; Mazurek MF; Martin JB
    Neurology; 1986 Feb; 36(2):294-7. PubMed ID: 2868429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular size distribution of somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with degenerative brain disease.
    Rissler K; Cramer H; Schaudt D; Strubel D; Gattaz WF
    Neurosci Res; 1986 Feb; 3(3):213-25. PubMed ID: 2871533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Behavioral correlates of cerebrospinal fluid amino acid and biogenic amine neurotransmitter alterations in dementia.
    Vermeiren Y; Le Bastard N; Van Hemelrijck A; Drinkenburg WH; Engelborghs S; De Deyn PP
    Alzheimers Dement; 2013 Sep; 9(5):488-98. PubMed ID: 23159046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low cerebrospinal fluid concentrations of peptide histidine valine and somatostatin-28 in Alzheimer's disease: altered processing of prepro-vasoactive intestinal peptide and prepro-somatostatin.
    Yasuda M; Maeda K; Kakigi T; Minamitani N; Kawaguchi T; Tanaka C
    Neuropeptides; 1995 Dec; 29(6):325-30. PubMed ID: 8837959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide histidine methionine in cerebrospinal fluid of patients with senile dementia of the Alzheimer type.
    Yasuda M; Minamitani N; Maeda K
    Jpn J Psychiatry Neurol; 1993 Mar; 47(1):85-90. PubMed ID: 8105129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy.
    Reinikainen KJ; Soininen H; Riekkinen PJ
    J Neurosci Res; 1990 Dec; 27(4):576-86. PubMed ID: 1981917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.